FibroBiologics granted extension by Nasdaq to regain compliance
Source: SeekingAlpha
2026-02-23 08:49:35 ET
More on FibroBiologics
- FibroBiologics announces $1.7M registered direct offering
- FibroBiologics announces payoff of outstanding debt
- Seeking Alpha’s Quant Rating on FibroBiologics
- Historical earnings data for FibroBiologics
- Financial information for FibroBiologics
Read the full article on Seeking Alpha
For further details see:
FibroBiologics granted extension by Nasdaq to regain compliance
FibroBiologics Inc.
NASDAQ: FBLG
FBLG Trading
-6.21% G/L:
$0.3143 Last:
604,854 Volume:
$0.34 Open:
FBLG Latest News
March 12, 2026 08:30:00 am
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
March 05, 2026 08:30:00 am
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
March 03, 2026 10:02:00 am
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
FBLG Stock Data
$17,774,070
39,126,900
0.21%
18
N/A
Biotechnology & Life Sciences
Healthcare
US
Houston
